Tech Daily Missouri: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Missouri.

Press releases published on November 2, 2026

Nov. 2, 2026

Humacyte To Announce 2026 Third Quarter Financial Results and Provide Business Update on November 10, 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation

Indeterminate GlobeNewswire

Nov. 2, 2026

NeOnc Technologies to Present Data from Its NEO100 and NEO212 Programs at the 31st Annual Meeting of the Society for Neuro-Oncology

Indeterminate GlobeNewswire

Nov. 2, 2026

Theriva™ Biologics anuncia la venta de SYN-004 (ribaxamasa) y la cartera de enzimas degradadoras de antibióticos asociada a Biossil Labs Inc.

Indeterminate GlobeNewswire

Nov. 2, 2026

CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer

Indeterminate GlobeNewswire

Nov. 2, 2026

RANE Partners with ISM to Help Global Supply Chain Professionals Get Ahead of Disruption

Indeterminate GlobeNewswire

Nov. 2, 2026

AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry

Indeterminate GlobeNewswire

Nov. 2, 2026

Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study

Indeterminate GlobeNewswire

Nov. 2, 2026

UroGen Announces First Patient Dosed in Phase 1 Trial of UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

Indeterminate GlobeNewswire

Nov. 2, 2026

Former Microsoft and Cisco Security Executive Edna Conway Joins Known Advisory Council

Indeterminate GlobeNewswire

Nov. 2, 2026

Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets

Indeterminate GlobeNewswire

Nov. 2, 2026

Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective

Indeterminate GlobeNewswire

Nov. 2, 2026

NowVertical Announces Resignation of Director

Indeterminate GlobeNewswire

Nov. 2, 2026

Innventure Announces Formation of Strategic Review Committee to Review Range of Capital Strategies

Indeterminate GlobeNewswire

Nov. 2, 2026

Lyell Immunopharma To Participate in November Investor Events

Indeterminate GlobeNewswire

Nov. 2, 2026

Fusemachines Launches New Video Series Showcasing Technology Maturity of HireFoundry.ai's Real-Time Interview Agent

Indeterminate GlobeNewswire

Nov. 2, 2026

SEALSQ to Host “Quantum Days” Event in Cannes as Official Sponsor of the First World Quantum Cannes Festival

Indeterminate GlobeNewswire

Nov. 2, 2026

Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response

Indeterminate GlobeNewswire

Nov. 2, 2026

AI Innovation Takes Center Stage at PowerPlan ELEVATE 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

Seerist Reports Record Third Quarter 2026: Revenue Up 26%, Federal ARR Up 37%, EBITDA Expands

Indeterminate GlobeNewswire